| 1 |
34198999 | Radioimmunotheranostic Pair Based on the Anti-HER2 Monoclonal Antibody: Influence of Chelating Agents and Radionuclides on Biological Properties. | 2021 Jun 27 |
1 |
| 2 |
29942011 | Development of an optimal imaging strategy for selection of patients for affibody-based PNA-mediated radionuclide therapy. | 2018 Jun 25 |
1 |
| 3 |
29977173 | Comparative Evaluation of Radioiodine and Technetium-Labeled DARPin 9_29 for Radionuclide Molecular Imaging of HER2 Expression in Malignant Tumors. | 2018 |
1 |
| 4 |
24643685 | HER2 expression in primary gastric cancers and paired synchronous lymph node and liver metastases. A possible road to target HER2 with radionuclides. | 2014 Jul |
1 |
| 5 |
23705574 | Influence of nuclides and chelators on imaging using affibody molecules: comparative evaluation of recombinant affibody molecules site-specifically labeled with ⁶⁸Ga and ¹¹¹In via maleimido derivatives of DOTA and NODAGA. | 2013 Jun 19 |
1 |
| 6 |
22228543 | Potential for clinical radionuclide-based imaging and therapy of common cancers expressing EGFR-family receptors. | 2012 Jun |
1 |
| 7 |
22872744 | HER2-positive tumors imaged within 1 hour using a site-specifically 11C-labeled Sel-tagged affibody molecule. | 2012 Sep |
2 |
| 8 |
22229017 | Pre-Clinical Assessment of Lu-Labeled Trastuzumab Targeting HER2 for Treatment and Management of Cancer Patients with Disseminated Intraperitoneal Disease. | 2011 Dec 22 |
1 |
| 9 |
19372467 | Targeting of HER2-expressing tumors with a site-specifically 99mTc-labeled recombinant affibody molecule, ZHER2:2395, with C-terminally engineered cysteine. | 2009 May |
2 |
| 10 |
18265976 | Therapy of human carcinoma xenografts with antibodies to EGFr and HER-2 conjugated to radionuclides emitting low-energy electrons. | 2008 Jul |
1 |
| 11 |
18930032 | Dimeric HER2-specific affibody molecules inhibit proliferation of the SKBR-3 breast cancer cell line. | 2008 Dec 12 |
1 |
| 12 |
17947470 | Evaluation of an 111In-radiolabeled peptide as a targeting and imaging agent for ErbB-2 receptor expressing breast carcinomas. | 2007 Oct 15 |
1 |
| 13 |
15989469 | In vitro characterization of a bivalent anti-HER-2 affibody with potential for radionuclide-based diagnostics. | 2005 Jun |
1 |
| 14 |
15150568 | HER2 expression in breast cancer primary tumours and corresponding metastases. Original data and literature review. | 2004 Jun 14 |
1 |
| 15 |
23638490 | 111In-Labeled anti-epidermal growth factor receptor Affibody PEP09239 | 2004 |
4 |
| 16 |
23700641 | 111In/68Ga-Labeled anti-epidermal growth factor receptor, native chemical ligation cyclized Affibody ZHER2:342min | 2004 |
4 |